Last UpdatedJuly 3, 2026
Written byTortAdvisor Editorial Team
Sources ReviewedFederal court, JPML, FDA and peer-reviewed research
Editorial StandardEstimates separated from confirmed litigation facts
Depo-Provera Settlement Amounts 2026 Update

Depo-Provera Settlement Amounts 2026: Payout Tiers and Case Value

Depo-Provera settlement amounts have not yet been established through a global court-approved settlement program. Any current payout figures are projections that may help organize claim-value factors—not confirmed averages, offers or guaranteed compensation.

Direct Answer Illustrative planning ranges may place lower-impact meningioma claims around $100,000–$300,000, surgery or moderate-impact claims around $300,000–$750,000, and severe, recurrent or permanently disabling claims around $750,000–$1.5 million+. These ranges are not derived from an announced Depo-Provera settlement matrix and an actual result could be lower, higher or zero.

As of the June 1, 2026 federal MDL report, 5,508 actions were pending in Depo-Provera MDL 3140. The court’s June 23, 2026 order addressed how preemption and Rule 702 rulings apply across individual actions, and the court lists a Rule 702 motions hearing for July 27, 2026.

5,508Pending MDL actions as of June 1, 2026
No Global DealNo announced court-approved personal-injury matrix
MeningiomaPrimary injury alleged in the centralized litigation
Primary-source court updates
FDA labeling cited
Estimates labeled clearly
Calculator disclosures included
No guaranteed outcome claims
Mobile-accessible calculator

Latest Depo-Provera Settlement Amounts and MDL 3140 Status

Federal Depo-Provera product-liability cases are centralized in MDL 3140 before Judge M. Casey Rodgers in the U.S. District Court for the Northern District of Florida. The June 1, 2026 JPML report listed 5,508 pending actions and 5,590 historical actions.

June 23, 2026
Pretrial Order No. 30A: The court addressed application of rulings on preemption and Rule 702 motions to individual actions.
July 27, 2026
Scheduled Rule 702 hearing: The court’s official MDL page lists a Rule 702 motions hearing. Expert-admissibility rulings can materially affect which causation theories proceed.
Current Status
No global personal-injury settlement announced: Projected payout ranges remain educational models rather than court-approved values.
Why the Rule 702 stage matters: Expert-evidence rulings can strengthen or weaken settlement leverage, but they do not guarantee that a settlement will occur or establish what an individual claim is worth.

Depo-Provera Settlement Amounts: Confirmed Facts vs. Projections

A trustworthy settlement-amount page should separate verified litigation facts from valuation modeling. This distinction is especially important before a formal settlement program exists.

What Is Confirmed

  • MDL 3140 is active in the Northern District of Florida.
  • The June 1, 2026 JPML report listed 5,508 pending actions.
  • Federal prescribing information includes a meningioma warning and monitoring language.
  • The litigation involves threshold proof of use and injury, expert evidence and individual case development.

What Is Not Yet Known

  • No global personal-injury settlement amount has been announced.
  • No court-approved injury tiers or point matrix have been published.
  • No reliable “average payout” exists for MDL 3140.
  • Future eligibility rules, deductions, liens and payment timing remain unknown.

Projected Depo-Provera Settlement Amounts by Injury Tier

The ranges below are illustrative valuation models based on injury severity, treatment burden, permanency, proof of Depo-Provera use and documented damages. They are not official settlement offers or predictions.

Illustrative Tier 1 $750K–$1.5M+

Severe or Catastrophic Claim

  • Recurrent, aggressive or surgically complex meningioma
  • Multiple procedures, radiation or permanent neurological injury
  • Major disability, future-care needs or substantial lost earning capacity
  • Strong product-use, diagnosis and causation documentation
Illustrative Tier 2 $300K–$750K

Surgery or Moderate Impact

  • One significant surgery or extended treatment
  • Persistent symptoms, recovery limitations or meaningful wage loss
  • Documented injection history and consistent medical timeline
  • Moderate future monitoring or impairment
Illustrative Tier 3 $100K–$300K

Lower Treatment Burden

  • Watch-and-wait monitoring or limited symptoms
  • No surgery or comparatively limited medical expense
  • Shorter or less complete documented use history
  • Lower economic loss or disputed causation factors
Projection warning: A claimant should not make financial, medical or legal decisions based on these figures. A future settlement program—if one is created—could use different categories, exclusions, deductions or values.

How TortAdvisor Estimates Depo-Provera Settlement Amounts

Because MDL 3140 has no announced payout matrix, TortAdvisor’s ranges are planning estimates rather than historical averages. We organize the same categories that commonly influence mass-tort valuation while clearly labeling the limits of the model.

1

Injury Severity

Tumor size, location, recurrence, neurological effects, surgery, radiation and prognosis.

2

Proof of Use

Injection records, pharmacy records, clinic records, insurance data and duration of use.

3

Economic Loss

Medical expenses, lost wages, reduced earning capacity, disability and future-care needs.

4

Litigation Risk

Causation evidence, preemption rulings, expert admissibility, jurisdiction and filing deadlines.

Editorial methodology: We update confirmed facts from primary sources, identify estimates as estimates, avoid describing projections as “average settlements,” and link users to the underlying court and FDA materials.

Depo-Provera Settlement Amounts by Claim Profile

Claim Profile Illustrative Range Factors That May Raise Value Factors That May Reduce Value
Monitoring / lower symptom burden $100,000–$300,000 Long documented use, clear diagnosis timing, ongoing surveillance and meaningful out-of-pocket costs. No treatment, incomplete use records, competing risk factors or limitations problems.
Surgery / moderate impairment $300,000–$750,000 Craniotomy, extended recovery, persistent symptoms, wage loss and strong pharmacy records. Good recovery, limited economic loss, short use duration or disputed product identity.
Recurrent / severe impairment $750,000–$1.5 million+ Multiple surgeries, radiation, cognitive or neurological disability, future care and major income loss. Causation disputes, alternative causes, evidentiary gaps or state-law defenses.
Wrongful death / catastrophic loss Case-specific; potentially above severe-injury tier Strong medical causation, dependency loss, funeral costs and substantial lifetime economic loss. Standing disputes, causation disputes, statutory damage limits or expired deadlines.

Who May Qualify for Depo-Provera Settlement Amounts?

Eligibility is not determined by a settlement calculator alone. A lawyer must review product use, diagnosis, timing, defendants, state law and available evidence.

Common Screening Factors

  • Use of Depo-Provera or injectable medroxyprogesterone acetate
  • Diagnosis of an intracranial meningioma after or during use
  • Medical imaging, pathology or neurology documentation
  • Pharmacy, clinic, OB/GYN, insurance or injection records
  • A claim that remains within the applicable filing period

Factors Requiring Closer Review

  • Generic product use or uncertain manufacturer identification
  • Incomplete injection records or uncertain treatment dates
  • Meningioma diagnosis before Depo-Provera exposure
  • Prior release, bankruptcy claim or settlement affecting rights
  • Other medical or legal causation issues

Read the full Depo-Provera lawsuit guide for litigation background, alleged failure-to-warn claims and eligibility details.

Factors That May Increase or Reduce Depo-Provera Settlement Amounts

Duration and Frequency of Use

Longer and better-documented injection histories may strengthen proof of exposure, but duration alone does not establish causation.

Tumor Severity and Location

Tumor location, size, recurrence and effects on vision, cognition, balance, speech or other neurological functions may influence damages.

Treatment Intensity

Craniotomy, radiation, hospitalization, rehabilitation and ongoing monitoring can increase documented medical damages.

Permanent Impairment

Long-term disability, cognitive changes, seizures, loss of independence and future-care needs may materially affect valuation.

Economic Damages

Past and future medical bills, lost earnings, reduced earning capacity, travel and caregiving costs require documentation.

Legal and Scientific Proof

Product identification, diagnosis timing, expert testimony, preemption issues and applicable state law can strengthen or reduce a claim.

Evidence Supporting Depo-Provera Settlement Amounts

Product-Use Records

  • Pharmacy and prescription records
  • OB/GYN or clinic injection logs
  • Insurance explanation-of-benefits records
  • Dates, dosage and duration of injections

Medical Records

  • MRI and CT imaging
  • Pathology and operative reports
  • Neurology and neurosurgery notes
  • Radiation, rehabilitation and follow-up records

Damages Documentation

  • Medical bills and insurance statements
  • Wage and employment records
  • Disability and future-care evidence
  • Travel, caregiving and household-service costs

Filing Deadlines for Depo-Provera Settlement Amount Claims

Filing deadlines can depend on the state, date of diagnosis, date a claimant reasonably discovered a possible connection, product manufacturer, claim type and other facts. Some states apply statutes of repose or special wrongful-death rules.

Do not rely on a general two- or three-year estimate. Waiting for bellwether trials or a future settlement can cause a claim to expire. An attorney should calculate the deadline for the specific jurisdiction and facts.

Estimate Factors Affecting Depo-Provera Settlement Amounts

Use the calculator to organize diagnosis severity, use history, treatment, impairment and economic loss. The result is educational and cannot predict an actual settlement.

Before You Start

  • Have approximate injection dates available.
  • Know the diagnosis and treatment history.
  • Gather major medical expenses and wage loss.
  • Treat the output as a planning estimate only.

Primary Sources and Medical Research

Confirmed litigation and labeling statements on this page are based on official federal sources. Peer-reviewed studies are included for medical context, not as individualized medical advice.

Orders by Date

MDL 3140 Orders by Date

Official source for case-management and pretrial orders, including June 23, 2026 Pretrial Order No. 30A.

Frequently Asked Questions About Depo-Provera Settlement Amounts

What is the average Depo-Provera settlement amount?

No reliable average exists because MDL 3140 has no announced global personal-injury settlement or court-approved payout matrix. Current ranges are projections, not historical averages.

How much could a severe Depo-Provera meningioma claim be worth?

Illustrative models sometimes place severe, recurrent or permanently disabling claims in a range of $750,000 to $1.5 million or more. This is not a guaranteed payout and an actual outcome could be lower, higher or zero.

Has Pfizer announced a Depo-Provera settlement?

No global court-approved personal-injury settlement program has been announced. The federal litigation remains active and is addressing expert evidence, preemption and individual case development.

How many Depo-Provera lawsuits are pending?

The June 1, 2026 JPML report listed 5,508 pending actions in MDL 3140. Case counts change as actions are filed, transferred, dismissed or resolved.

What evidence is most important?

Injection or pharmacy records, imaging, pathology, neurology records, treatment history, medical bills, wage-loss evidence and a clear use-and-diagnosis timeline are commonly important.

Is the settlement calculator legally binding?

No. The calculator provides an educational estimate based on limited inputs. It does not establish eligibility, create an attorney-client relationship or guarantee compensation.

Will every claimant receive the same amount?

No. Any future settlement may use injury tiers, proof requirements, points, deductions, liens and individual review. Claim values can differ substantially.

Should I wait for a settlement before contacting a lawyer?

No. Filing deadlines may expire before settlement negotiations occur. A lawyer should evaluate the claim and deadline promptly.

Use the Depo-Provera Settlement Amounts Calculator

Estimate a preliminary range based on diagnosis, treatment, injection history, impairment, evidence and economic loss. A licensed attorney must review the facts before providing legal advice.

Educational estimate
No guaranteed payout
Confidential review available

Author and Editorial Review

TortAdvisor Editorial Team

The TortAdvisor Editorial Team reviews federal MDL developments, public court orders, product-liability litigation and settlement-valuation issues. This page separates confirmed court and FDA information from projected payout modeling.

Review process: Litigation facts were checked against primary federal sources. Medical context is linked to FDA materials and peer-reviewed research. Estimated values are labeled as projections and do not imply a guaranteed result.

Legal, medical and settlement-estimate disclaimer: TortAdvisor is not a law firm and does not provide legal or medical advice. This page is educational and does not create an attorney-client relationship. Depo-Provera settlement amount ranges are projections, not court-approved schedules, offers, verdicts or guarantees. An actual claim may be worth less, more or nothing. Eligibility, causation, defendants, deadlines, liens, fees and net recovery depend on case-specific facts and applicable law. Consult a licensed attorney and healthcare professional for advice about your circumstances.

⚡ Free Confidential Case Evaluation

No fee unless you win · Open 24/7 · Completely confidential

Legal Disclaimer:By clicking "Submit My Case Evaluation," I provide my electronic signature and agree that TortAdvisor, operated by Waypoint Software LLC, and the law firms or marketing partners identified in the Partner List may call, text, or email me about my inquiry at the number and email I provide, including through automated technology, artificial or prerecorded voice, and SMS. Consent is not a condition of purchase or legal services. Message and data rates may apply. Reply STOP to opt out of SMS. I agree to the Terms and Privacy Policy.

Mason Arnao

About Mason Arnao

Mason David Arnao Mason David Arnao is an American entrepreneur, software engineer, and business executive based in Stuart, Florida. His career spans more than two decades in technology, automation, and lead generation systems. Arnao began his professional journey in the late 1990s as a computer technician for the National Basketball Association (NBA), where he was responsible for linking scoreboards, officials’ laptops, and stat monitors to broadcast networks. His technical precision and systems knowledge led him to join Professional Hospital Supply as a software engineer. There, he developed applications that improved data flow between medical suppliers and healthcare institutions, solidifying his foundation in enterprise-grade software development. By the early 2000's, Arnao advanced into web and SaaS infrastructure through Website Buddy LLC, a Florida-based development firm focused on building web tools for small businesses and online marketers. The experience refined his understanding of user-driven software and scalable online systems. In 2013, Arnao founded Waypoint Software, LLC, headquartered in Stuart, Florida. As President and Managing Partner, he built the company into a recognized provider of lead generation and real-time lead distribution technology. Waypoint’s software automates the acquisition, validation, and routing of consumer inquiries for marketing firms and data aggregators worldwide. The company serves hundreds of clients and is listed by the Better Business Bureau under “Sales Lead Generation.” Through Waypoint Software, Arnao has become a notable figure in the digital lead industry, combining technical engineering with automation strategy. His focus on system reliability, transparent data flow, and scalable integrations continues to position Waypoint as an industry leader in real-time lead management solutions.